Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response
Open accessThe DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Abstract
Alterations in gut microbiota impact the pathophysiology of several diseases, including cancer. Radiotherapy (RT), an established curative and palliative cancer treatment, exerts potent immune modulatory effects, inducing tumor-associated antigen (TAA) cross-priming with antitumor CD8+ T cell elicitation and abscopal effects. We tested whether the gut microbiota modulates antitumor immune response following RT distal to the gut. Vancomycin, an antibiotic that acts mainly on gram-positive bacteria and is restricted to the gut, potentiated the RT-induced antitumor immune response and tumor growth inhibition. This synergy was dependent on TAA cross presentation to cytolytic CD8+ T cells and on IFN-γ. Notably, butyrate, a metabolite produced by the vancomycin-depleted gut bacteria, abrogated the vancomycin effect. In conclusion, depletion of vancomycin-sensitive bacteria enhances the antitumor activity of RT, which has important clinical ramifications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mouse models, certain gut commensals mediate efficacy of anticancer therapies, including chemotherapy, radiotherapy, and immunotherapies such as adoptive T cell transfer, intratumoral CpG-oligonucleotides, and ICIs.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High serum levels of butyrate and propionate have been associated with resistance to anti-CTLA-4 antibodies and radiotherapy and increased Treg cell numbers in patients with melanoma.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“whereas some studies found that gut commensals were able to impact tumor growth independently [33, 138].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Self-citationSearch and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 20,826
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894 · cited 3×
“FastTree 2--approximately maximum-likelihood trees for large alignments.”
MethodUniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227 · cited 1×
“(77) were computed between each pair of samples using QIIME.”
MethodGut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549 · cited 1×
“SCFAs produced by colonic Clostridia were also shown to induce the differentiation of colonic Treg cells in mice (68).”
BackgroundRole of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · cited 1×
“Although DCs can also modulate T cells in a butyrate-dependent manner (67), to our knowledge, the direct impact on antigen presentation in the context of RT has not been investigated.”
BackgroundGut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Research works printed but not linked: 1
- 10.1038/nature14292 · DOI · Paper page
Cited by
Items 101–200 of 316
You, L., Zhou, J., Xin, Z., Hauck, J. S., Na, F., Tang, J., Zhou, X., Lei, Z., & Ying, B. (2022) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbac005 · Cited by 35
The role of short-chain fatty acids in cancer prevention and cancer treatment
Kalyanaraman, B., Cheng, G., & Hardy, M. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110172 · Cited by 34
“Gut bacteria-derived butyrate inhibited ionizing radiation-induced interferon in the tumor microenvironment [64].”
Chen, X., Yang, M., Huang, Y., Tu, J., Cai, Y., & Yuan, X. (2025) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359251387534 · Cited by 37
“Uribe-Herranz et al. 131 showed that oral vancomycin depleted butyrate-producing bacteria (e.g., Clostridia), relieving inhibitory effects on DCs and enhancing RT-induced antigen cross-presentation, boosting IFN-γ -dependent CD8 + T-cell responses, and improving clearance of distant tumors.”
Jia, L., Cao, M., Chen, H., Zhang, M., Dong, X., Ren, Z., Sun, J. T., & Pan, L. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07701 · Cited by 29
Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies
Rinninella, E., Raoul, P. C., Cintoni, M., Palombaro, M., Pulcini, G., Gasbarrini, A., & Mele, M. C. (2021) · Microorganisms · doi:10.3390/microorganisms9071469 · Cited by 28
Gut Microbiota: A Potential Target for Cancer Interventions
Zhou, H., Yuan, Y., Wang, H., Xiang, W., Li, S., Zheng, H., Wen, Y., Yang, M., Chen, L., & Zhou, J. (2021) · Cancer Management and Research · doi:10.2147/cmar.s328249 · Cited by 30
“The changes in grampositive intestinal flora reshaped the tumor microenvironment, increased the antigen presentation of draining lymph nodes, and improved the anti-tumor effect of radiotherapy.(111) Indole-3-propionic acid (IPA) is derived from intestinal microorganisms and is a tryptophan deamination product with int…”
BackgroundRegulation of T cell repertoires by commensal microbiota
Kim, K. S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1004339 · Cited by 36
“Frontiers in Cellular and Infection Microbiology 08 dysfunction and the translocation of gut microbes, which can be induced by total body irradiation used for adoptive CAR T cell transfer (Uribe-Herranz et al., 2020) or ICI treatment (Mager et al.”
BackgroundUnderstanding and harnessing triple-negative breast cancer-related microbiota in oncology
Devoy, C., Bueso, Y. F., & Tangney, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1020121 · Cited by 33
Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target
Pierini, S., Tanyi, J. L., Simpkins, F. A., George, E. M., Uribe‐Herranz, M., Drapkin, R., Burger, R. A., Morgan, M. A., & Facciabene, A. (2020) · JCI Insight · doi:10.1172/jci.insight.136773 · Cited by 28
Self-citationChallenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer
Plavc, G., Jesenko, T., Oražem, M., & Strojan, P. (2020) · Cancers · doi:10.3390/cancers12113197 · Cited by 29
“As butyrate otherwise impairs DC antigen presentation to CD8+ T cells, vancomycin enhanced direct and abscopal antitumor activity of hypofractionated RT [163].”
BackgroundThe Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy
Kim, J.-H., & Lee, H. K. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0032 · Cited by 29
“Vancomycin-depleted gut microbiota not only affects the antitumor immune response but also increases the antitumor activity of radiation therapy (Uribe-Herranz et al., 2020).”
BackgroundWu, M., Tian, C., Zou, Z., Min, J., & Liu, H. (2024) · Cancers · doi:10.3390/cancers16203547 · Cited by 29
“In the mouse model, the augmentation of radiation’s anticancer effects was evident when Gram-positive bacteria were eradicated by antibiotics [138].”
BackgroundCancer and the Microbiome of the Human Body
Herrera‐Quintana, L., Vázquez‐Lorente, H., López-Garzón, M., Cortés‐Martín, A., & Plaza‐Díaz, J. (2024) · Nutrients · doi:10.3390/nu16162790 · Cited by 27
Karamanolis, N. N., Kounatidis, D. C., Vallianou, N. G., Dimitriou, K., Tsaroucha, E., Tsioulos, G., Anastasiou, I. A., Mavrothalassitis, E., Karampela, Ι., & Dalamaga, Μ. (2024) · Antibiotics · doi:10.3390/antibiotics14010009 · Cited by 29
HO-1 impairs the efficacy of radiotherapy by redistributing cGAS and STING in tumors
Zhang, C., Deng, Z., Wu, J., Ding, C., Li, Z., Xu, Z., Chen, W., Yang, K., Wei, H., He, T., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci181044 · Cited by 29
Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
Taitz, J., Tan, J., Ni, D., Potier‐Villette, C., Grau, G. E., Nanan, R. K. H., & Macia, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1493991 · Cited by 37
An anxious relationship between Autism Spectrum Disorder and Gut Microbiota: A tangled chemistry?
Vellingiri, B., Aishwarya, S. Y., Jancy, S. B., Abhishek, G. S., Babu, H. W. S., Vijayakumar, P., Narayanasamy, A., Mariappan, S., Sangeetha, R., Gopalakrishnan, A. V., et al. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.03.003 · Cited by 33
The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments
Son, Y. M., & Kim, J. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2208.08002 · Cited by 26
“Similarly, treatment of vancomycin an antibiotic that mainly acts on gram-positive bacteria in the gut, was found to enhance the crosspresentation of tumor-associated antigen (TAA) on DCs and to promote the activation of cytolytic CD8 T cells [72].”
BackgroundAntibiotics, cancer risk and oncologic treatment efficacy: a practical review of the literature
Lopes, M. S. M., Machado, L. M., Silva, P. A. I. A., Uchiyama, A. A. T., Yen, C. T., Ricardo, E. D., Mutão, T. S., Pimento, J. R., Shimba, D. S., Hanriot, R. D. M., et al. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1106 · Cited by 29
“Animal studies have shown that vancomycin use, an antibiotic that acts against Gram-positive bacteria and is restricted to the intestinal tract, promotes an increase in the antitumour potential of radiotherapy despite greater toxicity [84].”
BackgroundLiu, L., Liang, L., Luo, Y., Han, J., Lu, D., Cai, R., Sethi, G., & Mai, S. (2024) · Research · doi:10.34133/research.0529 · Cited by 22
Microbiota substances modulate dendritic cells activity: A critical view
Shvets, Y. V., Khranovska, N., Senchylo, N., Ostapchenko, D., Tymoshenko, I., Onysenko, S., Kobyliak, N. M., & Falalyeyeva, T. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27125 · Cited by 27
“Interestingly, propionate-treated DCs also exhibited a partial inhibition of antigen presentation when used alone but did not potentiate the inhibition induced by butyrate alone [94].”
BackgroundMicrobiome modulation of tumorigenesis and immune responses
Chen, Y., Fang, Y., Lyu, Z., Tian, Y., Niu, S., Li, Y.-R., & Yang, L. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-025-01208-9 · Cited by 30
“…DC-mediated tumor antigen cross-presentation: in a melanoma model, antibiotic depletion of butyrate-producing gut commensals led to heightened DC cross-priming of tumor antigens and stronger CD8 + T cell responses after radiotherapy, whereas reintroducing butyrate abrogated this effect [172] .”
Liu, W. L., Pi, Z., Wang, X., Shang, C., Song, C., Wang, R., He, Z., Zhang, X., Wan, Y., & Mao, W. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104322 · Cited by 25
The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy
Madkour, M. A., Altaf, R. A., Sayed, Z. S., Yasen, N. S., Elbary, H. A., Elsayed, R. A., Mohamed, E. N., Toema, M., Wadan, A.-H. S., Nafady, M. H., et al. (2024) · Advanced Gut & Microbiome Research · doi:10.1155/2024/9919868 · Cited by 25
The microbiome and gynecologic cancer: cellular mechanisms and clinical applications
Chalif, J., Wang, H., Spakowicz, D. J., Quick, A. M., Arthur, E. K., O’Malley, D. M., & Chambers, L. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2023-004894 · Cited by 28
Microbial metabolites: novel therapeutic tools for boosting cancer therapies
Luu, M., & Visekruna, A. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.08.005 · Cited by 20
The cure from within? a review of the microbiome and diet in melanoma
Kumar, P. R., Brazel, D., DeRogatis, J. M., Goldstein, J. B., Whiteson, K., Chow, W. A., Tinoco, R., & Moyers, J. T. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10029-3 · Cited by 25
“This synergy was mediated through CD8 + T cells and interferon gamma [89].”
BackgroundGut dysbiosis impacts the immune system and promotes prostate cancer
Shyanti, R. K., Greggs, J., Malik, S., & Mishra, M. K. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106883 · Cited by 26
Precision strategies for cancer treatment by modifying the tumor-related bacteria
Lu, H., Wang, Q., Liu, W., Wen, Z., & Li, Y. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11491-9 · Cited by 22
Yu, X., Liu, F., Qiu, B., Li, Y., Xie, X., Guo, J., Wu, L., Liang, T., Wang, D., Wang, J., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.892401 · Cited by 22
Gut microbiota: a potential target for improved cancer therapy
Zhao, M., Jiang, G., Zhou, H., Li, J., Xiang, W., Li, S., Wang, H., & Zhou, J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04546-5 · Cited by 20
Nutrient acquisition of gut microbiota: Implications for tumor immunity
Wang, Y., Huang, J., Tong, H., Jiang, Y., Yu, J., & Ma, X. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.003 · Cited by 20
Hylander, B. L., Qiao, G., Gomez, E. C., Singh, P. K., & Repasky, E. A. (2023) · Biochimie · doi:10.1016/j.biochi.2023.01.016 · Cited by 18
“Uribe-Herranz Uribe-Herranz et al. [ 63 ] reported that vancomycin depletion of butyrate On the other hand, some taxa are observed to be enriched at thermoneutrality, although we were not able to identify as consistent changes as what we observed in the ST mice.”
ResultJiang, L., Li, B., Zhang, Y., Ma, S., Liu, C., Liang, F., Wei, Z., Huang, T., & Wang, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.615439 · Cited by 23
“Radiation can reduce resistance to commonly used antibiotics, and vancomycin pretreatment can enhance the antitumor effects of radiation in vivo by increasing antigen presentation and cytotoxic T cell infiltration into the tumor, through modulation of the gut microbiota (32, 35).”
BackgroundMalard, F., Thépot, S., Cluzeau, T., Carré, M., Lebon, D., Bories, P., Legrand, O., Schwarz, M., Loschi, M. L., Meunier, M., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015571 · Cited by 22
Commensal microbes and p53 in cancer progression
Celardo, I., Melino, G., & Amelio, I. (2020) · Biology Direct · doi:10.1186/s13062-020-00281-4 · Cited by 17
“Hence, depletion of vancomycin-sensitive bacteria is proposed to enhance the antitumor activity of radiotherapy [43].”
Mattiola, I., & Diefenbach, A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101724 · Cited by 19
Wu, Q. D., Zhang, Y., Wang, C., Hou, Y., He, W., Wang, L., Xiong, J., Ren, Z., Wang, H., Sui, B., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00656-23 · Cited by 17
Gut microbiota: a crucial player in the combat against tuberculosis
Jie, L., Chen, D., Yan, Y., Pi, J., Xu, J.-F., Chen, L., & Zheng, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1442095 · Cited by 18
Lipidomic-Based Advances in Diagnosis and Modulation of Immune Response to Cancer
Gil‐de‐Gómez, L., Balgoma, D., & Montero, O. (2020) · Metabolites · doi:10.3390/metabo10080332 · Cited by 16
“The levels of butyrate are also correlated with the responsiveness to melanoma in mice treated with antibiotics [96].”
BackgroundSelf-citationRadojević, D., Tomić, S., Mihajlović, D., Tolinački, M., Pavlović, B., Vučević, D., Bojić, S., Golić, N., Čolić, M. J., & Đokić, J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1921927 · Cited by 18
“On the other hand, the study by Mireia Uribe-Herranz et al.(45) on cancer model in mice showed that the success of adoptive anticancer T cells transfer, as cancer therapy, is associated with the presence of different groups of bacteria in mice gut microbiome.”
ResultThe bacteria inside human cancer cells: Mainly as cancer promoters
Zhu, W., Wang, J., Liu, Z., & Wei, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.897330 · Cited by 28
“In vitro studies have shown that oral vancomycin induces the reduction of Gram-positive bacteria in the intestine and is associated with the enhanced efficacy of radiation therapy in melanoma, lung cancer, and cervical cancer models, which may possibly be through interferon-g and CD8 T cell-dependent mechanisms (79).”
BackgroundGut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer
Yuan, H., Gui, R., Wang, Z., Fang, F., & Zhao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128774 · Cited by 18
Targeting systemic and gut microbial metabolism in ER+ breast cancer
Heath, H., Mogol, A. N., Casiano, A. S., Zuo, Q., & Madak‐Erdogan, Z. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.12.008 · Cited by 18
Ji, G., Zhao, J., Si, X., & Song, W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115345 · Cited by 18
Mantri, A., Klümpen, L., Seel, W., Krawitz, P. M., Stehle, P., Weber, B., Koban, L., Plaßmann, H., & Simon, M. (2024) · Nutrients · doi:10.3390/nu16132082 · Cited by 18
Daillère, R., Routy, B., Goubet, A., Cogdill, A. P., Ferrere, G., Silva, C. A.-C., Fluckiger, A., Ly, P., Haddad, Y., Pizzato, E., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1794423 · Cited by 17
“Notably, butyrate, a metabolite produced by the vancomycin-depleted gut bacteria, abrogated the vancomycin effect.(40) In fact, high levels of butyrate and propionate in the blood are associated with resistance to CTLA-4 blockade and an increase in the abundance of Treg cells.”
BackgroundPharmacomicrobiomics in precision cancer therapy: bench to bedside
Ngoc, K. L., Pham, T. T. H., Nguyen, T. K., & Huong, P. T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1428420 · Cited by 20
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials
Niu, Y., Feng, J., Ma, J., Xiao, T., & Yuan, W. (2025) · Exploration · doi:10.1002/exp.20210185 · Cited by 26
The microbiota in radiotherapy-induced cancer immunosurveillance
Chen, J., Deutsch, É., Kroemer, G., Galluzzi, L., & Zitvogel, L. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01052-8 · Cited by 19
“In contrast to intestinal low-dose radiotherapy, low-dose radiotherapy delivered directly to the tumour failed to reverse resistance to ICIs in patients with advanced-stage NSCLC 166 .”
InfluentialGonzález-Brito, A., & Uribe‐Herranz, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1083303 · Cited by 14
Self-citationThe role of short-chain fatty acid metabolism in the pathogenesis, diagnosis and treatment of cancer
Hou, M., Yu, Q., Yang, L., Zhao, H., Jiang, P., Qin, L. Y., & Zhang, Q. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1451045 · Cited by 16
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold
Turchan, W. T., Pitroda, S. P., & Weichselbaum, R. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179573 · Cited by 15
“Recent evidence also suggests that the microbiome affects anti-tumor immune responses induced by both ICB [55] and radiotherapy [56,57], and therefore this could be a point of further investigation going forward.”
BackgroundGiudice, E., Salutari, V., Ricci, C., Nero, C., Carbone, M. V., Ghizzoni, V., Musacchio, L., Landolfo, C., Perri, M. T., Camarda, F., et al. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103542 · Cited by 16
Paziewska, M., Szelest, M., Kiełbus, M., Masternak, M., Zaleska, J., Wawrzyniak, E., Kotkowska, A., Siemieniuk‐Ryś, M., Morawska, M., Kalicińska, E., et al. (2024) · Oncology Letters · doi:10.3892/ol.2024.14685 · Cited by 15
Shi, Y., Guo, Z., Wang, Q., & Deng, H. (2024) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_41_24 · Cited by 14
The Role of Intestinal Flora in Anti-Tumor Antibiotic Therapy
Ye, X., Wang, A., Lin, W., Xu, Y., Dong, X., Zhou, Y., Tian, K., & Xu, X. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2710281 · Cited by 16
“Recent research has shown that intestinal flora can interact with antibiotics to stimulate immunity [60–63] and regulate tumor micro-environment [9,62,64–66].”
BackgroundMethodInfluentialJoseph, N. T., Shankar, S. R., Narasimhamurthy, R. K., Rao, B. S. S., & Mumbrekar, K. D. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1770361 · Cited by 13
“Modifying gut microbiota can also enhance tumor killing by radiotherapy (Uribe-Herranz et al. 2020).”
BackgroundWu, L., Li, Y., Wang, W., Deng, L., Ge, H., Cui, M., & Bi, N. (2025) · Med · doi:10.1016/j.medj.2025.100877 · Cited by 13
Cedó, L., Madeira, A., & Caro, P. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.10.007 · Cited by 14
Perales-Linares, R. F., Leli, N. M., Mohei, H., Beghi, S., Rivera, O. D., Κωστόπουλος, Ν., Giglio, A., George, S. S., Uribe‐Herranz, M., Costabile, F., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2499 · Cited by 16
Self-citationGut Microbial Dysbiosis in the Pathogenesis of Leukemia: An Immune-based Perspective.
Goswami, M., & Bose, P. D. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104211 · Cited by 12
Ding, T., Chen, Q., Liu, H., Zhang, H., Sun, Y., Zhao, L., Gao, Y., & Wei, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37511 · Cited by 14
Zhang, W., Zhang, H., Gao, Y., Lei, J., & Suo, C. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1596688 · Cited by 17
Wu, C., Shao, Y., & Gu, W. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03091-y · Cited by 16
“Studies have found that oral vancomycin-depleted vancomycin-susceptible bacteria in mice regulate the antigen presentation of dendritic cells and enhance radiotherapy-induced IFN-γ-dependent anti-tumor effects [98].”
BackgroundFeigenberg, S. J., Costabile, F., Tanes, C., Bittinger, K. L., O'Connor, R., Agarwal, D., Skoufos, G., Salaris, S., Hatzigeorgiou, A. G., Κωστόπουλος, Ν., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011356 · Cited by 15
Self-citationTargeting gut microbiota and metabolites in cancer radiotherapy
Ma, S., Li, X., Shang, S., Zhai, Z., Wu, M., Song, Q., & Chen, D. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70481 · Cited by 17
“91 In summary, SCFAs exhibit dual roles, acting as both anti-tumour agents and factors that reduce RT sensitivity by modulating the TME.”
The Role of the Microbiome and of Radiotherapy-Derived Metabolites in Breast Cancer
Herrera‐Quintana, L., Vázquez‐Lorente, H., Silva, R. C. M. C., Arancibia, J. E. O., Reyes-Amigo, T., Pires, B. R. B., & Plaza‐Díaz, J. (2024) · Cancers · doi:10.3390/cancers16213671 · Cited by 12
Li, T., Liu, T., Zhao, Z., Pan, Y., Xu, X., Zhang, Y., Zhan, S., Zhou, S., Zhu, W., Guo, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911325 · Cited by 13
Radiation Therapy and the Microbiome; More Than a Gut Feeling
Amit, U., Facciabene, A., & Ben‐Josef, E. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000650 · Cited by 11
“These results have been shown both in a human papillomavirus E7–expressing lung/cervical cancer model and in an ovalbuminexpressing melanoma model.(53) Vancomycin pretreatment enhanced the antitumor effects of RTon the primary and the abscopal tumor in mice.”
BackgroundMethodResultInfluentialSelf-citationMicrobes little helpers and suppliers for therapeutic asthma approaches
Reuter, S., Raspe, J., & Taube, C. (2024) · Respiratory Research · doi:10.1186/s12931-023-02660-7 · Cited by 13
“For example, in a murine tumor model, the elimination of gram-positive bacteria led to a more effective DC-dependent anti-tumor response following radiotherapy [63].”
BackgroundBartolini, I., Risaliti, M., Tucci, R., Muiesan, P., Ringressi, M. N., Taddei, A., & Amedei, A. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i11.1616 · Cited by 13
Rühle, A., Zou, J., Glaser, M., Halle, L., Gkika, E., Schäfer, H. S., Knopf, A., Becker, C., Grosu, A., Popp, I., et al. (2023) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-023-07868-3 · Cited by 16
“For instance, vancomycin has been found to potentiate the radiotherapy-induced antitumor immune response by eliminating butyrate-producing bacteria in preclinical models [27].”
BackgroundUribe‐Herranz, M., Oliver‐Caldés, A., Martínez-Micaelo, N., Español‐Rego, M., Val-Casals, M., Martínez-Soler, R., Rubio-García, E., Brunello, V., Mihelic, E. Z., Klein-González, N., et al. (2025) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0203 · Cited by 12
Self-citationHost-microbiota interactions in genitourinary cancer immunotherapy
Xu, X., Cui, J., Li, W., Xu, Y., Yuan, S., Zeng, X., & Li, B. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.005 · Cited by 12
Huang, H., Peng, S., Liu, Y., Chen, L., & Wu, F. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07885-w · Cited by 11
Yao, Y., Ye, Y., & Zheng, C. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70121 · Cited by 12
“Additionally, the microbiota regulates the maturation and function of dendritic cells, influencing their activation and differentiation of T cells, thereby controlling immune responses [24, 25].”
Gut microbiome and cancer implications: Potential opportunities for fermented foods
Crowder, S. L., Jim, H., Hogue, S., Carson, T. L., & Byrd, D. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188897 · Cited by 12
Antibiotics impair immunotherapy for urothelial cancer
Derosa, L., & Zitvogel, L. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0373-1 · Cited by 9
Bouges, E., Segers, C., Leys, N., Lebeer, S., Zhang, J., & Mastroleo, F. (2023) · Cancers · doi:10.3390/cancers15245859 · Cited by 9
The Skin Microbiome: A New Key Player in Melanoma, From Onset to Metastatic Stage
L'Orphelin, J. ‐., Dompmartin, A., & Dréno, B. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13224 · Cited by 14
“Elevated serum levels of butyrate and propionate have been linked to resistance to anti- CTLA-4 and an increase in Treg cells in melanoma patients (Uribe-Herranz et al. 2020; Coutzac et al. 2020).”
Liang, F., Sun, Y., Yang, J., Shen, Z., Wang, G., Zhu, J., Zhou, C., & Xia, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1562831 · Cited by 12
Gut–lung axis in allergic rhinitis: microbial dysbiosis and therapeutic strategies
Yang, W., Wu, H., Li, X., Wan, Z., Kong, W., & Huang, C. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1654997 · Cited by 12
Zhao, B., Nuli, R., Jiao, Y., Zhang, B., Wang, L., & Guan, Y. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709278 · Cited by 9
“Not only are there more than 10 14 microorganisms in the human intestine, but large numbers of immune cells and immune factors are also present [9].”
BackgroundJiao, X., Zhang, D.-X., Chen, C., Kong, L., Hu, X., Shan, X., & Ai-dong, Q. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108660 · Cited by 9
Harnessing the Gut Microbiota to Potentiate the Efficacy of CAR T Cell Therapy
Gabrielli, G., Shouval, R., Ghilardi, G., van den Brink, M. R. M., & Ruella, M. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000950 · Cited by 11
Felchle, H., Brunner, V., Groll, T., Walther, C. N., Nefzger, S. M., Zaurito, A. E., Silva, M. G., Gissibl, J., Topping, G. J., Rotgerink, L. L., et al. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.10.008 · Cited by 10
Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
Li, B., Gong, T., Hao, Y., Zhou, X., & Cheng, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.721249 · Cited by 9
Huo, T., Zhu, B., Shan, X., Song, J., Wang, Z., Zhou, J., Zhang, X., Bai, Y., Liu, C., Zhao, Y., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.159871 · Cited by 10
Molecular hydrogen as a potential mediator of the antitumor effect of inulin consumption
Pascal‐Moussellard, V., Alcaraz, J., Tanguy, S., Salomez‐Ihl, C., Cinquin, P., Boucher, F. R., & Boucher, E. (2025) · Scientific Reports · doi:10.1038/s41598-025-96346-3 · Cited by 12
“Additionally, in vivo administration of butyrate has been shown to counteract the antitumor effects of radiotherapy and vancomycin in mice with B16 melanoma 65 .”
Unraveling the Role of the Microbiota in Cancer Immunotherapy: A New Frontier
Wang, S., Li, S., Zhang, M., Liu, R., Ye, X., Mao, S., Yu, J., Xie, X., & Tan, W. (2025) · Research · doi:10.34133/research.0744 · Cited by 13
Jia, R. F., Xiao, C., Zhang, Y., Hu, L.-Y., Jun-jun, Y., Zuo, R., Hu, Y., Xie, Y.-H., Ma, X., Li, Q., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101311 · Cited by 11
Dendritic cell maturation in the tumor microenvironment
Miao, Y., Liu, Y., Tang, H., & Zhang, Z. (2023) · National Science Open · doi:10.1360/nso/20220053 · Cited by 12
“In addition, short-chain fatty acids produced by intestinal microbes interfere with the IL-12 production of mouse LAMP3 + DCs, thereby impairing radiotherapy-induced CD8 + T cell responses [133].”
BackgroundCSF-1R+ Macrophages Control the Gut Microbiome–Enhanced Liver Invariant NKT Function through IL-18
Ma, C., McCallen, J., McVey, J. C., Trehan, R., Bauer, K. C., Zhang, Q., Ruf, B., Wang, S., Lai, C. W., Trinchieri, G., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200854 · Cited by 9
Nakatsu, G. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15715 · Cited by 10
Glycopeptide Antibiotics: Genetics, Chemistry, and New Screening Approaches
Yushchuk, O., & Ostash, B. O. (2022) · Springer eBooks · doi:10.1007/978-981-16-6132-7_16 · Cited by 8
Goat milk oligosaccharides: regulating infant immunity by intervention in the gut microbiota
Liu, S., Zeng, X., Li, J., Li, W., Gu, Y., Li, B., & Wang, J. (2025) · Food & Function · doi:10.1039/d5fo00162e · Cited by 9
Cogels, M., Caluwé, A. D., Buisseret, L., & Penninckx, S. (2026) · OncoImmunology · doi:10.1080/2162402x.2025.2608436 · Cited by 9
Diet, microbiome, and probiotics establish a crucial link in vaccine efficacy
Dutta, S., Chatterjee, N., Gallina, N. L. F., Kar, S., Koley, H., Nanda, P. K., Biswas, O., Das, A. K., Biswas, S., Bhunia, A. K., et al. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2480230 · Cited by 9
“Gut microbes and probiotics modulate dendritic cell (Dc) functions (Alagón Fernández del campo et al. 2019; Uribe-Herranz et al. 2020). the Dcs act as APcs and present the vaccine antigens to t cells, thereby regulating immune response quality, magnitude, and duration. the short-chain fatty acids…”
Combined Therapy with microRNA-Expressing Salmonella and Irradiation in Melanoma
Yoon, W., Park, Y., Kim, S., Park, Y., & Kim, C. Y. (2021) · Microorganisms · doi:10.3390/microorganisms9112408 · Cited by 7
“Recently, the abscopal effect, which was used by Mole in 1953, has gained the attention of researchers with the advent of immunotherapy [31,32].”
Background
Metadata
- Authors
- Uribe-Herranz, M., Rafail, S., Beghi, S., Gil-de-Gómez, L., Verginadis, I., Bittinger, K., Pustylnikov, S., Pierini, S., Perales-Linares, R., Blair, I. A., Mesaros, C. A., Snyder, N. W., Bushman, F., Koumenis, C., & Facciabene, A.
- Affiliations
- University of Pennsylvania (US)
- Children's Hospital of Philadelphia (US)
- Drexel University (US)
- Corresponding author
- Koumenis, Constantinos
- Facciabene, Andrea
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2019-12-09
- Volume
- 130
- Issue
- 1
- Pages
- 466-479
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6934221
- OpenAlex
- W2993330612
- Cited by
- 316
- References
- 79
- Citations by year
- 2026: 37 · 2025: 59 · 2024: 60 · 2023: 52 · 2022: 44 · 2021: 43 · 2020: 21
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Children's Hospital of Philadelphia
- University of Pennsylvania
- National Institutes of Health
- National Cancer Institute (R01CA116779, R01CA219871)
- National Institute of General Medical Sciences (R01GM132261)
- National Institute of Environmental Health Sciences (P30ES013508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- gut microbiota, radiotherapy, dendritic cells, antigen presentation, antitumor immunity, vancomycin, butyrate, CD8+ T cells, interferon-gamma, abscopal effect
- MeSH terms
- Gastrointestinal Microbiome, Animals, Antigens, Neoplasm, Butyrates, Dendritic Cells, Female, Neoplasms, Experimental, Antigen Presentation, Mice, Knockout, CD8-Positive T-Lymphocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.